Cancer remedy comprising anthranilic acid derivative as active ingredient

Details for Australian Patent Application No. 2001234089 (hide)

Owner Teijin Limited

Inventors Tsuruo, Takashi; Yamori, Takao; Kawamura, Takashi; Takeyasu, Takumi; Tsuchiya, Naoki

Agent Davies Collison Cave

Pub. Number AU-B-2001234089

PCT Pub. Number WO01/60354

Priority 2000-36386 15.02.00 JP

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 11 August 2005

International Classifications

A61K 031/196

A61P 035/00 Antineoplastic agents

A61K 031/215

Event Publications

11 August 2005 Application Accepted

  Published as AU-B-2001234089

8 December 2005 Standard Patent Sealed

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001234090-Novel inulin synthase and process for producing inulin by using the same

2001234088-Tnf-alpha inhibitors